Beta-blockade in the management of systolic dysfunction

Veterinary Clinics of North America - Small Animal Practice

Volumn 34, Issue 5, 2004, Pages 1157-1170

  Abbott, Jonathan A ^a  

^a VIRGINIA MARYLAND REGIONAL COLLEGE OF VETERINARY MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ALDOSTERONE; ANGIOTENSIN; ATENOLOL; BETA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; BETA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; BUCINDOLOL; CARVEDILOL; ENDOTHELIN; LABETALOL; METOPROLOL; NORADRENALIN; RENIN; VASOPRESSIN;

ADRENERGIC SYSTEM; BETA ADRENERGIC RECEPTOR BLOCKING; BRADYCARDIA; CONGESTIVE HEART FAILURE; DISEASE ASSOCIATION; DOG DISEASE; DRUG EFFICACY; DRUG INDICATION; DRUG MECHANISM; DRUG SAFETY; DRUG SELECTIVITY; HEART FUNCTION; HYPOTENSION; MORTALITY; MUSCLE WEAKNESS; NEUROENDOCRINOLOGY; NONHUMAN; PATHOPHYSIOLOGY; PATIENT MONITORING; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SURVIVAL; SYSTOLIC BLOOD PRESSURE; VASODILATATION; VETERINARY MEDICINE;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; CAT DISEASES; CATS; DOG DISEASES; DOGS; HEART FAILURE, CONGESTIVE; HUMANS; SYSTOLE;

CANIS FAMILIARIS;

EID: 4444266236     PISSN: 01955616     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cvsm.2004.05.008     Document Type: Review

References (74)

1. Hoffman B.B. Lefkowitz R.J. Taylor P. Neurotransmission: the autonomic and somatic motor nervous sytems In: Hardman J.G. Limbird L.E. editors, Goodman & Gilman's the pharmacological basis of therapeutics 9th edition 1996 105-140 McGraw-Hill New York
2. Ahlquist R.P. A study of the adrenotropic receptors Am J Physiol 153 1948 586-600
3. Hoffman B.B. Lefkowitz R.J. Catecholamines, sympathomimetic drugs, and adrenergic receptor antagonists In: Hardman J.G. Limbird L.E. editors, Goodman & Gilman's the pharmacological basis of therapeutics 9th edition. 1996 199-248 McGraw-Hill New York
4. Cheng H.J. Zhang Z.S. Onishi K. et al. Upregulation of functional beta(3)-adrenergic receptor in the failing canine myocardium Circ Res 89 2001 599-606
5. Gauthier C. Tavernier G. Charpentier F. et al. Functional beta3-adrenoceptor in the human heart J Clin Invest 98 1996 556-562
6. Schrier R.W. Abraham W.T. Hormones and hemodynamics in heart failure N Engl J Med 341 1999 577-585
7. Colucci W.S. Molecular and cellular mechanisms of myocardial failure Am J Cardiol 80 1997 15L-25L
8. Meurs K.M. Fox P.R. Miller M.W. et al. Plasma concentrations of tumor necrosis factor-alpha in cats with congestive heart failure Am J Vet Res 63 2002 640-642
9. Cohn J.N. Rector T.S. Prognosis of congestive heart failure and predictors of mortality Am J Cardiol 62 1988 25-30A
10. Cohn J.N. Levine T.B. Olivari M.T. et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure N Engl J Med 311 1984 819-823
11. Re G. Bergamasco L. Badino P. et al. Canine dilated cardiomyopathy: lymphocyte and cardiac alpha(1)- and beta-adrenoceptor concentrations in normal and affected great danes Vet J 158 1999 120-127
12. Ware W.A. Lund D.D. Subieta A.R. et al. Sympathetic activation in dogs with congestive heart failure caused by chronic mitral valve disease and dilated cardiomyopathy J Am Vet Med Assoc 197 1990 1475-1481
13. Marin-Neto J.A. Pintya A.O. Gallo Junior L. et al. Abnormal baroreflex control of heart rate in decompensated congestive heart failure and reversal after compensation Am J Cardiol 67 1991 604-610
14. Zucker I.H. Wang W. Modulation of baroreflex and baroreceptor function in experimental heart failure Basic Res Cardiol 86 Suppl 3 1991 133-148
15. Bristow M.R. Minobe W. Rasmussen R. et al. Beta-adrenergic neuroeffector abnormalities in the failing human heart are produced by local rather than systemic mechanisms J Clin Invest 89 1992 803-815
16. Bristow M.R. Pathophysiologic and pharmacologic rationales for clinical management of chronic heart failure with beta-blocking agents Am J Cardiol 71 1993 12-22C
17. Mann D.L. Kent R.L. Parsons B. et al. Adrenergic effects on the biology of the adult mammalian cardiocyte Circulation 85 1992 790-804
18. Communal C. Singh K. Pimentel D.R. et al. Norepinephrine stimulates apoptosis in adult rat ventricular myocytes by activation of the beta-adrenergic pathway Circulation 98 1998 1329-1334
19. Knowlton K.U. Michel M.C. Itani M. et al. The alpha 1A-adrenergic receptor subtype mediates biochemical, molecular, and morphologic features of cultured myocardial cell hypertrophy J Biol Chem 268 1993 15374-15380
20. Chakraborti S. Chakraborti T. Shaw G. Beta-adrenergic mechanisms in cardiac diseases: a perspective Cell Signal 12 2000 499-513
21. Borgarelli M. Badino P. Bergamasco L. et al. Lymphocyte beta-adrenoceptor downregulation in great danes with occult dilated cardiomyopathy (DCM) and with DCM and heart failure Vet J 158 1999 128-134
22. Bristow M.R. Beta-adrenergic receptor blockade in chronic heart failure Circulation 101 2000 558-569
23. Talwar K.K. Bhargava B. Upasani P.T. et al. Hemodynamic predictors of early intolerance and long-term effects of propranolol in dilated cardiomyopathy J Card Fail 2 1996 273-277
24. Azevedo E.R. Kubo T. Mak S. et al. Nonselective versus selective beta-adrenergic receptor blockade in congestive heart failure: differential effects on sympathetic activity Circulation 104 2001 2194-2199
25. Gilbert E.M. Abraham W.T. Olsen S. et al. Comparative hemodynamic, left ventricular functional, and antiadrenergic effects of chronic treatment with metoprolol versus carvedilol in the failing heart Circulation 94 1996 2817-2825
26. Currie P.J. Kelly M.J. McKenzie A. et al. Oral beta-adrenergic blockade with metoprolol in chronic severe dilated cardiomyopathy J Am Coll Cardiol 3 1984 203-209
27. Ikram H. Fitzpatrick D. Double-blind trial of chronic oral beta blockade in congestive cardiomyopathy Lancet 2 1981 490-493
28. Swedberg K. Hjalmarson A. Waagstein F. et al. Prolongation of survival in congestive cardiomyopathy by beta-receptor blockade Lancet 1 1979 1374-1376
29. Waagstein F. Hjalmarson A. Varnauskas E. et al. Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy Br Heart J 37 1975 1022-1036
30. Engelmeier R.S. O'Connell J.B. Walsh R. et al. Improvement in symptoms and exercise tolerance by metoprolol in patients with dilated cardiomyopathy: a double-blind, randomized, placebo-controlled trial Circulation 72 1985 536-546
31. Bristow M.R. Gilbert E.M. Abraham W.T. et al. Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators Circulation 94 1996 2807-2816
32. Bristow M.R. O'Connell J.B. Gilbert E.M. et al. Dose-response of chronic beta-blocker treatment in heart failure from either idiopathic dilated or ischemic cardiomyopathy. Bucindolol Investigators Circulation 89 1994 1632-1642
33. van Campen L.C. Visser F.C. Visser C.A. Ejection fraction improvement by beta-blocker treatment in patients with heart failure: an analysis of studies published in the literature J Cardiovasc Pharmacol 32 Suppl 1 1998 S31-S35
34. The Cardiac Insufficiency Bisoprolol Study II. (CIBIS-II): a randomised trial Lancet 353 1999 9-13
35. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF) Lancet 353 1999 2001-2007
36. Packer M. Bristow M.R. Cohn J.N. et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group N Engl J Med 334 1996 1349-1355
37. Packer M. Coats A.J. Fowler M.B. et al. Effect of carvedilol on survival in severe chronic heart failure N Engl J Med 344 2001 1651-1658
38. Cleland J.G. Beta-blockers for heart failure: why, which, when, and where Med Clin N Am 87 2003 339-371
39. A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure N Engl J Med 344 2001 1659-1667
40. Andreka P. Aiyar N. Olson L.C. et al. Bucindolol displays intrinsic sympathomimetic activity in human myocardium Circulation 105 2002 2429-2434
41. Hajjar R.J. MacRae C.A. Adrenergic-receptor polymorphisms and heart failure N Engl J Med 347 2002 1196-1199
42. Small K.M. Wagoner L.E. Levin A.M. et al. Synergistic polymorphisms of beta1- and alpha2C-adrenergic receptors and the risk of congestive heart failure N Engl J Med 347 2002 1135-1142
43. Rush J.E. Freeman L.M. Hiler C. Brown D.J. Use of metoprolol in dogs with acquired cardiac disease J Vet Cardiol 4 2002 23-28
44. Tidholm A. Falk T. Gundler S. et al. Effect of thyroid hormone supplementation on survival of euthyroid dogs with congestive heart failure due to systolic myocardial dysfunction: a double-blind, placebo-controlled trial Res Vet Sci 75 2003 195-201
45. Sabbah H.N. Shimoyama H. Kono T. et al. Effects of long-term monotherapy with enalapril, metoprolol, and digoxin on the progression of left ventricular dysfunction and dilation in dogs with reduced ejection fraction Circulation 89 1994 2852-2859
46. Morita H. Suzuki G. Mishima T. et al. Effects of long-term monotherapy with metoprolol CR/XL on the progression of left ventricular dysfunction and remodeling in dogs with chronic heart failure Cardiovasc Drugs Ther 16 2002 443-449
47. Sabbah H.N. Sharov V.G. Gupta R.C. et al. Chronic therapy with metoprolol attenuates cardiomyocyte apoptosis in dogs with heart failure J Am Coll Cardiol 36 2000 1698-1705
48. Nemoto S. Hamawaki M. De Freitas G. et al. Differential effects of the angiotensin-converting enzyme inhibitor lisinopril versus the beta-adrenergic receptor blocker atenolol on hemodynamics and left ventricular contractile function in experimental mitral regurgitation J Am Coll Cardiol 40 2002 149-154
49. Tsutsui H. Spinale F.G. Nagatsu M. et al. Effects of chronic beta-adrenergic blockade on the left ventricular and cardiocyte abnormalities of chronic canine mitral regurgitation J Clin Invest 93 1994 2639-2648
50. Golf S. Hansson V. Effects of beta blocking agents on the density of beta adrenoceptors and adenylate cyclase response in human myocardium: intrinsic sympathomimetic activity favours receptor upregulation Cardiovasc Res 20 1986 637-644
51. Liang C.S. Frantz R.P. Suematsu M. et al. Chronic beta-adrenoceptor blockade prevents the development of beta-adrenergic subsensitivity in experimental right-sided congestive heart failure in dogs Circulation 84 1991 254-266
52. i alpha-proteins in patients with congestive heart failure Eur J Clin Pharmacol 51 1996 127-132
53. Flesch M. Ettelbruck S. Rosenkranz S. et al. Differential effects of carvedilol and metoprolol on isoprenaline-induced changes in beta-adrenoceptor density and systolic function in rat cardiac myocytes Cardiovasc Res 49 2001 371-380
54. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The SOLVD Investigators N Engl J Med 325 1991 293-302
55. CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS) N Engl J Med 316 1987 1429-1435
56. Ettinger S.J. Benitz A.M. Ericsson G.F. et al. Effects of enalapril maleate on survival of dogs with naturally acquired heart failure. The Long-Term Investigation of Veterinary Enalapril (LIVE) Study Group J Am Vet Med Assoc 213 1998 1573-1577
57. Fung J.W. Yu C.M. Yip G. et al. Effect of beta blockade (carvedilol or metoprolol) on activation of the renin-angiotensin-aldosterone system and natriuretic peptides in chronic heart failure Am J Cardiol 92 2003 406-410
58. Eichhorn E.J. McGhie A.L. Bedotto J.B. et al. Effects of bucindolol on neurohormonal activation in congestive heart failure Am J Cardiol 67 1991 67-73
59. Holmer S.R. Hengstenberg C. Mayer B. et al. Marked suppression of renin levels by beta-receptor blocker in patients treated with standard heart failure therapy: a potential mechanism of benefit from beta-blockade J Intern Med 249 2001 167-172
60. Nagatsu M. Spinale F.G. Koide M. et al. Bradycardia and the role of beta-blockade in the amelioration of left ventricular dysfunction Circulation 101 2000 653-659
61. Kubo T. Azevedo E.R. Newton G.E. et al. Lack of evidence for peripheral alpha(1)-adrenoceptor blockade during long-term treatment of heart failure with carvedilol J Am Coll Cardiol 38 2001 1463-1469
62. Uechi M. Sasaki T. Ueno K. et al. Cardiovascular and renal effects of carvedilol in dogs with heart failure J Vet Med Sci 64 2002 469-475
63. Lysko P.G. Webb C.L. Gu J.L. et al. A comparison of carvedilol and metoprolol antioxidant activities in vitro J Cardiovasc Pharmacol 36 2000 277-281
64. Poole-Wilson P.A. Swedberg K. Cleland J.G.F. et al. Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol or Metoprolol European Trial (COMET): randomised controlled trial Lancet 362 2003 7-13
65. Hjalmarson A. Waagstein F. COMET: a proposed mechanism of action to explain the results and concerns about dose Lancet 362 2003 1077
66. Massie B.M. A comment on COMET: how to interpret a positive trial? J Card Fail 9 2003 425-428
67. Packer M. Do [beta]-blockers prolong survival in heart failure only by inhibiting the [beta]1-receptor? A perspective on the results of the COMET trial J Card Fail 9 2003 429-443
68. Wikstrand J. Fagerberg B. Goldstein S. et al. COMET: a proposed mechanism of action to explain the results and concerns about dose Lancet 362 2003 1076-1077
69. Monnet E. Orton E.C. Salman M. et al. Idiopathic dilated cardiomyopathy in dogs: survival and prognostic indicators J Vet Intern Med 9 1995 12-17
70. Tidholm A. Svensson H. Sylven C. Survival and prognostic factors in 189 dogs with dilated cardiomyopathy J Am Anim Hosp Assoc 33 1997 364-368
71. Calvert C.A. Pickus C.W. Jacobs G.J. et al. Signalment, survival, and prognostic factors in Doberman pinschers with end-stage cardiomyopathy J Vet Intern Med 11 1997 323-326
72. Bolger A.P. Al-Nasser F. Beta-blockers for chronic heart failure: surviving longer but feeling better? Int J Cardiol 92 2003 1-8
73. Kittleson M.D. Eyster G.E. Knowlen G.G. et al. Myocardial function in small dogs with chronic mitral regurgitation and severe congestive heart failure J Am Vet Med Assoc 184 1984 455-459
74. Abbott J.A. Broadstone R.V. Pyle R.L. Hemodynamic effects of oral carvedilol in healthy conscious dogs [abstract] J Vet Intern Med 17 2003 441